Kongressthemen Clinical trials in paediatric populations still pose several challenges and often many studies remain un- published. 10 years on from the introduction of EU Paediatric Investigation Plans (PIPs) there are still many lessons to be learned about the planning and execution of trials which should be tailored around the needs of children. Recent advancements in immuno-oncology research has led to an increase in clinical trials to treat cancer in children and adolescents.
Kongressorganizer (PCO) SMi Group
Anmerkungen Speakers: Amgen, AstraZeneca, GSK, Health Protection Agency, Kite Pharma, MHRA, Otsuka Europe Development and Commercialisation Ltd, Public Health England, Pfizer Inc., Roche Pharma Schweiz AG, Saint Joan de Deu Research Foundation, Sanofi, Takeda
Kongressgebühr GBP 1.499,00 (Book by 30th November to save GBP 400: GBP 1099.00,
Book by 15th December and save GBP 200: GBP 1299.00,
ook by 31st January and save GBP 100: GBP 1399.00,
Standard: GBP 1499.00)
Veranstalter Kontakt 83 Great Titchfield Street W1W 6RH London Großbritannien
